Riboflavin tetrabutyrate
核黄素四丁酸酯
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameRiboflavin tetrabutyrate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1986/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A
Develop Information
Active CompaniesChengdu Leer Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A